FIELD: medicine; pharmacology.
SUBSTANCE: invention refers to injection solution based on agents of vitamin B group and lydocaine giving beneficial effect on inflammatory and degenerative nervous and motor system diseases, having analgesic action, providing increase of blood flow and blood formation. Injection solution contains the following components: thiamine chloride, pyridoxine hydrochloride, cyanocobalamin, lydocaine hydrochloride, sodium hydroxide, benzetonium chloride, trilon B and injection water. Injection solution is non-toxic and can be applied for patients suffering from depressed liver function and needy for medical treatment with this agent.
EFFECT: solution is non-toxic.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INJECTABLE COMPOSITION BASED ON GROUP B VITAMINS AND LIDOCAINE | 2014 |
|
RU2589824C1 |
| PHARMACEUTICAL COMPOSITION ELICITING ANALGETIC EFFECT, IMPROVING BLOOD SUPPLY, STIMULATING REGENERATION OF NERVOUS TISSUE AND ANTI-ALLERGIC EFFECT | 2003 |
|
RU2225707C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING VASCULAR DISORDERS AND NEUROPATHIES | 2013 |
|
RU2521199C1 |
| INJECTION FORM OF PHARMACEUTICAL COMPOSITION (VERSIONS) FOR PREVENTING AND TREATING NEUROPATHIES AND METHOD FOR PREPARING IT | 2010 |
|
RU2448706C2 |
| NONSTEROID ANTIINFLAMMATORY MEDICINAL AGENT | 2007 |
|
RU2345775C1 |
| NON-STEROID ANTI-INFLAMMATORY DRUG | 2007 |
|
RU2464984C2 |
| EXTERNAL AND LOCAL PHARMACEUTICAL STEPHAGLABRIN PREPARATION | 2007 |
|
RU2364399C1 |
| STEPHAGLABRIN-BASED PHARMACEUTICAL COMPOSITION OF LOCAL AND EXTERNAL APPLICATION FOR TREATMENT OF TRAUMATIC AND POST-OPERATION INJURY OF PERIPHERAL NERVOUS SYSTEM | 2007 |
|
RU2371172C2 |
| PHARMACEUTICAL COMPOSITION FOR PARENTERAL DRIP INTRODUCTION (VERSIONS) | 2019 |
|
RU2707948C1 |
| VITAMIN COMPLEX-CONTAINING RECTAL SUPPOSITORIES | 2000 |
|
RU2177782C1 |
